WHO ICTRP trial
Does dehydroepiandrosterone (DHEA) improve IVF outcomes in poor responders?
ISRCTN78447218 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN78447218 |
|---|---|
| Public title | Does dehydroepiandrosterone (DHEA) improve IVF outcomes in poor responders? |
| Scientific title | Does dehydroepiandrosterone (DHEA) improve IVF outcomes in poor responders? A randomised, double-blind, placebo-controlled trial |
| Primary sponsor | Homerton University Hospital NHS Foundation Trust (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | United Kingdom;England;Scotland |
| Conditions | Infertility Pregnancy and Childbirth Infertility |
| Interventions | Controlled ovarian hyperstimulation and in-vitro fertilisation. Two groups of poor responders going through IVF (200 in each group). Intervention: 75 mg DHEA daily Control: placebo to take for 10 weeks before their IVF |
| Registration date | Oct 29, 2013 |
| Target size | 400 |
| Secondary IDs | 2013-001661-16;FE 1202 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: